- Home
- CPAY vs DGX Comparison
CPAY vs DGX Comparison
Compare CPAY & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPAY
- DGX
- Stock Information
- Founded
- CPAY 1986
- DGX 1967
- Country
- CPAY United States
- DGX United States
- Employees
- CPAY N/A
- DGX N/A
- Industry
- CPAY EDP Services
- DGX Medical Specialities
- Sector
- CPAY Technology
- DGX Health Care
- Exchange
- CPAY Nasdaq
- DGX Nasdaq
- Market Cap
- CPAY 22.2B
- DGX 20.1B
- IPO Year
- CPAY 2010
- DGX 1996
- Fundamental
- Price
- CPAY $325.08
- DGX $180.31
- Analyst Decision
- CPAY Buy
- DGX Buy
- Analyst Count
- CPAY 14
- DGX 15
- Target Price
- CPAY $394.33
- DGX $185.40
- AVG Volume (30 Days)
- CPAY 555.3K
- DGX 842.9K
- Earning Date
- CPAY 08-06-2025
- DGX 10-21-2025
- Dividend Yield
- CPAY N/A
- DGX 1.78%
- EPS Growth
- CPAY 6.87
- DGX 12.66
- EPS
- CPAY 14.72
- DGX 8.35
- Revenue
- CPAY $4,171,325,000.00
- DGX $10,522,000,000.00
- Revenue This Year
- CPAY $13.72
- DGX $11.12
- Revenue Next Year
- CPAY $10.44
- DGX $3.41
- P/E Ratio
- CPAY $22.11
- DGX $21.53
- Revenue Growth
- CPAY 9.22
- DGX 12.58
- 52 Week Low
- CPAY $269.02
- DGX $146.17
- 52 Week High
- CPAY $400.81
- DGX $185.62
- Technical
- Relative Strength Index (RSI)
- CPAY 52.65
- DGX 57.30
- Support Level
- CPAY $309.50
- DGX $176.97
- Resistance Level
- CPAY $331.55
- DGX $185.62
- Average True Range (ATR)
- CPAY 8.35
- DGX 2.61
- MACD
- CPAY 1.79
- DGX 0.24
- Stochastic Oscillator
- CPAY 81.50
- DGX 58.90
About CPAY Corpay Inc.
Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses. Its suite of modern payment solutions helps customers manage vehicle-related expenses, lodging expenses, and corporate payments. Its reportable segments are; Vehicle Payments, Corporate Payments, Lodging Payments, and Other. The group's geographic areas are the United States, Brazil, the United Kingdom, and Other.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.